The Carlumab Biosimilar Anti-CCL2 Antibody is a cutting-edge biopharmaceutical product designed for research and therapeutic applications involving CCL2, a cytokine that plays a key role in inflammation and immune response regulation. This antibody, produced using innovative biosimilar technology, offers high specificity and affinity for human CCL2, making it a powerful tool for studying CCL2 functions in various disease models, including cancer, autoimmune disorders, and chronic inflammatory conditions.Carlumab, also known as anti-MCP-1 antibody, has shown promising results in preclinical studies for its potential to modulate the inflammatory response and hinder tumor growth by targeting the CCL2 signaling pathway.
Its ability to neutralize CCL2 activity makes it a valuable asset in developing novel therapeutic approaches for diseases characterized by dysregulated immune responses and excessive inflammation.Researchers and clinicians can utilize the Carlumab Biosimilar Anti-CCL2 Antibody to investigate the intricate mechanisms underlying CCL2-mediated immune regulation and explore its therapeutic potential in treating inflammatory disorders and cancer. By understanding the role of CCL2 in disease pathogenesis and immune modulation, this antibody opens new avenues for developing precision therapies that target the immune microenvironment and improve patient outcomes.
Product Name:
Carlumab (Anti-CCL2) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0113
Target:
CCL2
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
CNTO 888
Description:
Anti-CCL2(carlumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
